Historical record - last NADAC effective date: 2/17/2021
Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Lifestar Pharma LLC, priced at $0.1691 per EA under NDC 70756080730. Its NADAC has been published 146 times since May 16, 2018.
FDA first approved this application on Aug 30, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Lifestar Pharma LLCNDC
70756080730
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
2/17/2021
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205868FDA Approved
8/30/2017
TE Code
AB
On Market Since
6/4/2018
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 146 times since May 16, 2018, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1691 per EA |
|---|---|
| All-time high | $0.2139 (Aug 15, 2018) |
| All-time low | $0.1519 (Sep 23, 2020) |
| Median price | $0.1739 |
| Average price | $0.1759 |
| Largest weekly change | -14.2% (Nov 21, 2018) |
| Weeks tracked | 146 |
| Tracking since | May 16, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-18.2%
Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Lifestar Pharma LLC, is $0.1691 per EA (NDC 70756080730), effective Feb 24, 2021.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 18.2%. It has been tracked across 146 weekly CMS publications since May 16, 2018.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since May 16, 2018, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.1519 (Sep 23, 2020) to a high of $0.2139 (Aug 15, 2018), with a median of $0.1739 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG CAPSULE, is $0.1061 per EA — about 37% below LANSOPRAZOLE DR 30 MG CAPSULE.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 70756080730) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.